Results 21 to 30 of about 757,915 (376)
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Drugs, 2021 Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and in those with structural lung disease such as cystic fibrosis. Epidemiological
D. Reynolds, M. Kollef
semanticscholar +1 more source
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
International Journal of Molecular Sciences, 2021 Pseudomonas aeruginosa is a dominant pathogen in people with cystic fibrosis (CF) contributing to morbidity and mortality. Its tremendous ability to adapt greatly facilitates its capacity to cause chronic infections.
Irene Jurado-Martín +2 more
semanticscholar +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 Pseudomonas aeruginosa is an opportunistic pathogen causing nosocomial infections in severely ill and immunocompromised patients. Ubiquitously disseminated in the environment, especially in hospitals, it has become a major threat to human health due to ...
Chongbing Liao +4 more
semanticscholar +1 more source
Frontiers in Microbiology, 2021 Pseudomonas aeruginosa is the most prevalent bacterial species that contribute to cystic fibrosis (CF) respiratory failure. The impaired function of CF transmembrane conductance regulator leads to abnormal epithelial Cl–/HCO3– transport and acidification
Qiao Lin +2 more
doaj +1 more source
Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
International Journal of Molecular Sciences, 2022 Antimicrobial resistance is an old and silent pandemic. Resistant organisms emerge in parallel with new antibiotics, leading to a major global public health crisis over time.
A. Lorusso +4 more
semanticscholar +1 more source
Reference Module in Biomedical Sciences, 2020 This datasheet on Pseudomonas aeruginosa covers Identity, Overview, Distribution, Hosts/Species Affected, Further Information.
A. Bashir, Jeremy S. Brown
semanticscholar +1 more source
Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
Emerging Microbes and Infections, 2022 Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are carbapenem-resistant, while globally the percentage varies considerably.
F. Tenover, D. Nicolau, C. Gill
semanticscholar +1 more source
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Infectious Disease and Therapy, 2022 Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa isolates are frequent causes of serious nosocomial infections that may compromise the selection of antimicrobial therapy. The goal of this review is to summarize recent
Ashlan J. Kunz Coyne +4 more
semanticscholar +1 more source
Mobile Carbapenemase Genes in Pseudomonas aeruginosa
Frontiers in Microbiology, 2021 Carbapenem-resistant Pseudomonas aeruginosa is one of the major concerns in clinical settings impelling a great challenge to antimicrobial therapy for patients with infections caused by the pathogen.
Eun-Jeong Yoon, S. Jeong
semanticscholar +1 more source
Respiratory Research, 2021 Background Pseudomonas aeruginosa is one of the commonest bacteria colonizing the airway in patients with non-cystic fibrosis bronchiectasis. Pseudomonas aeruginosa colonization is associated with poor outcomes in patients with bronchiectasis, including ...
Wang Chun Kwok +4 more
doaj +1 more source